APR-1051
APR-1051-001
Phase 1 small_molecule active
Quick answer
APR-1051 for Advanced Solid Tumor is a Phase 1 program (small_molecule) at Aprea Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aprea Therapeutics
- Indication
- Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active